CONTINENTAL STRATEGY, LLC

Lobbying for DEXCOM · Healthcare company that develops, manufactures, produces, and distributes CGMs.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · $75,000.00 income · posted Jan 19, 2026

Lobbying activity 2

Health Issues

continuous glucose monitoring

Medical/Disease Research/Clinical Labs

continuous glucose monitoring

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.